(Chloromethyl)(cyclopropyl)dimethylsilane (3c) is also a known compound (Doklady Chem. 1975, 222, 322.) , but was prepared in another way as follows. A slurry of magnesium (9.95 g, 0.415 gatom) and iodine (one piece) in THF (300 ml) was cooled in an ice bath, and to this was added bromocyclopropane (33.0 ml, 0.415 mol) under an Ar atmosphere during 30 min. After the addition had been completed, the mixture was further stirred at an ambient temperature for 30 min. The resulting solution was cooled again in an ice bath, and a THF (50 ml) solution of chloro(chloromethyl)dimethylsilane (53.9 g, 0.377 mol) was added to it during 30 min. Stirring was continued for 20 h at an ambient temperature, then the mixture was poured into a solution of NH 4 Cl-H 2 O and the whole was extracted with Et 2 O. Usual work-up followed by distillation afforded 3c (40.87 g, 73%) as a colorless fragrant oil at 151-154°C/760 mmHg. Silicon-containing GABA derivatives silagaba for neuropathic pain without CNS-related side effects -3.4, 11.7, 11.8, 13.8, 16.1, 26.8, 26.9, 33.2, 62.6, 117.5, 167 
Enzymatic hydrolysis of 5a,b,c to form (S)-5a,b,c and (R)-6a,b,c:
The procedure for the preparation of (S)-5c and (R)-6c is described as a representative example. Novozyme 435 ® (Sigma-Aldrich L4777, 20 mg, 1 mg/mmol) was added to an emulsified solution of dl-5c (4.78 g, 20.0 mmol) in phosphate buffer (0.1 M, pH 7.4, 83.5 ml) and DMSO (16.5 ml) at 13-14°C (internal) and the mixture was stirred at the same temperature for 48 h. The enzyme was filtered off and rinsed with EtOAc. The filtrate and EtOAc washing were combined and HCl-H 2 O (1 N) was added to make the mixture acidic (pH ca.2-3). The whole was extracted with EtOAc, and the organic layer was washed with water several times. Usual work-up left an oil (ca. 4.6 g). Na 2 CO 3 -H 2 O (5% w/v) was added to the oil and the mixture was thoroughly extracted with EtOAc. The aqueous layer was made acidic (pH 2-3) with HCl-H 2 O (10%), and extracted with EtOAc. Washing of the acidic EtOAc layer with water (several times) followed by usual work-up provided crude R rich-6c (R/S=ca. 5.5, ca 69%ee, 1.88 g, ca. 45%). The optical purity was estimated from its 1 H-NMR spectrum in the presence of Chirabite AR ® . On the other hand, the basic EtOAc layer was washed with saturated Silicon-containing GABA derivatives silagaba for neuropathic pain without CNS-related side effects
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NH 4 Cl-H 2 O and then treated as usual to afford crude S rich-5c (S/R=ca. 4.4, ca. 63%ee, 2.60 g, ca. 54%), which was subjected to re-resolution reaction without further purification. The E-value was calculated to be 10.3. The crude R rich-6c (1.88 g) was dissolved in CH 2 Cl 2 (18 ml), and to this solution were added successively Et 3 N (1.49 ml, 1.2 equiv.), ethyl chloroformate (0.94 ml, 1.1 equiv.), and 4-DMAP (54 mg, 5 mol%). The mixture was stirred in an ice bath for 2 h, then dilute HCl-H 2 O was added and the whole was extracted with EtOAc. The organic layer was washed with saturated NaHCO 3 -H 2 O and then treated as usual to provide R rich-5c (2.07 g) which was subjected to re-resolution reaction without further purification. The crude S rich-5c (2.60 g) was stirred with Novozyme 435 (11 mg, 1 mg/mmol) in a similar manner to that described above for 72 h to afford (S)-5c (1.82 g, ca. 38% overall) whose R enantiomer content was undetectable (NMR), along with 6c (S/R=ca. 1, 0.67 g, ca. 16%).
The crude R rich-5c (2.07 g) was also re-treated with Novozyme 435 (7 mg, 0.8 mg/mmol) for 72 h to give enantiomerically pure (R)-6c (0.91 g, 22% overall) along with R rich-5c (R/S=ca. 2.5, 1.00 g, ca.21%).
In the same manner as above, (S)-5a,b,c and (R)-6a,b,c were all obtained in ca. 25-35% yield by repeated enzymatic resolution until the undesired antipode become undetectable in the 1 H-NMR spectra with Chirabite. These products were crude (only extractive isolation), but were sufficiently pure for use in the following hydrogenation reaction. The E-value for dl-5a was 16.7 (40 mmol scale), and that for dl-5b was 7.6 (20 mmol scale).
Hydrogenation of crude (R)-6a,b,c and (S)-5a,b,c to form (R)-and (S)-2a,b,c:
The procedures for the preparation of (R)-2c from (R)-6c and (S)-2c from (S)-5c are described as typical examples.
To a solution of (R)-6c (2.31 g, 10.9 mmol) in MeOH (36.5 ml), KOH-H 2 O (20%w/v, 6.1 ml, 2 equiv.), and H 2 O (12.1 ml) [eventually 0.2 M solution in MeOH-H 2 O (2:1)] was added Raney Ni (1.1 ml). The mixture was efficiently stirred under a hydrogen atmosphere (0.45 MPa) at ambient temperature for 48 h, then filtered through a Celite pad. The collected catalyst was rinsed with MeOH and then with H 2 O (14.5 ml). Glacial HOAc (1.28 ml, 2.05 equiv.) was added to the combined filtrate and MeOH-H 2 O washings. MeOH was evaporated under reduced pressure to leave a volume of ca. 30 ml, which was left to stand for precipitation of a crystalline product. The crystals were collected by filtration, and washed with H 2 O, and then dried over P 2 O 5 in vacuo. Recrystallization of the dried crystals from MeOH-2-PrOH, or of the aqueous filtrate from MeOH-H 2 O provided (R)-2c (1.63 g, 69%) as colorless fine needles, mp: 171-172°C (MeOH-2-PrOH). Drastic change of the mp was occasionally observed due to partial γ-lactam formation during heating on the hot plate (hereinafter the same for other GABA derivatives 2). 1 H-NMR (CD 3 OD) δ: -0.38 (1H, dddd, J=9.5, 9.5, 7, 7 Hz), -0.04 (6H, s), 0.24 (2H, ddd, J=7, 5, 109.4. The optical purity was confirmed as follows. After determination of the NMR spectrum in CD 3 OD, the solvent was removed and the recovered (R)-2c was heated without any solvent in an oil bath at 180°C for 15 min. During this time (R)-2c cyclized to the crude γ-lactam which contained no detectable antipode, as judged from its 1 H-NMR (CDCl 3 ) with Chirabite.
A solution of (S)-5c (1.82 g, 7.6 mmol) in KOH-H 2 O (20%w/v, 2.8 ml, 1.3 equiv.) and MeOH (8 ml) was gently refluxed with stirring for 1 h. The mixture was then cooled, and transferred to a Parr vessel with the aid of MeOH (2.2 ml) and H 2 O (0.8 ml). KOH-H 2 O (20%w/v, 1.5 ml, 0.7 equiv.) and Raney Ni (0.61 ml) were added to the vessel, and the reaction mixture was efficiently stirred under a hydrogen atmosphere (0. C, 48.44; H, 10.16; N, 7.06. Found: C, 48.57; H, 9.89; N, 7.05. CD (c 0.0547, MeOH, 25°C) The CD spectra of (R)-2a,b,c and (S)-2a,b,c described above were all consistent with those of (R)-and (S)-3-isobutyl-GABA [pregabalin antipode and pregabalin (1) itself], respectively, which were synthesized in a similar manner as above starting from ethyl cyanoacetate and isobutyraldehyde (see the CD plots below). The absolute structures were also confirmed by single-crystal X-ray analysis of urea 8 derived from (R)-2a by way of 7 as follows.
X-ray analysis of 8 derived from (R)-2a:
A crystal of 8 for X-ray analysis was prepared in two steps. A slurry of (R)-2a (227 mg, 1.20 mmol) in THF (15 ml) was stirred with (R)-(+)-α-methylbenzyl isocyanate (140 µl, 1.00 mmol) at ambient temperature for 65 h. After evaporation of the solvent, HCl-H 2 O (10%) was added to the residue and the mixture was extracted with CHCl 3 . Usual work-up afforded crude-7 (231 mg). To a CH 2 Cl 2 (10 ml) solution of the crude-7
were added 4-bromoaniline (234 mg, 1.36 mmol), 4-dimethylaminopyridine (8 mg, 65.6 µmol), and EDC⋅HCl (198 mg, 1.03 mmol), and the mixture was stirred at ambient temperature for 24 h. HCl-H 2 O (10%) was added and the whole was extracted with CHCl 3 . Usual work-up followed by Silicon-containing GABA derivatives silagaba for neuropathic pain without CNS-related side effects Theta range for data collection 1.57 to 27.83°.
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Index ranges -14<=h<=13, -12<=k<=12, -12<=l<=17 
